Skip to content
Care, coaching and clear next steps.
I start here!
Menu
← All articles

Everyday support

Semaglutide Side Effects: Common Symptoms and When to Get Help

Understand common semaglutide side effects, serious warning signs, and why Wegovy and Ozempic trial rates depend on the product, dose and population.

Educational content. Clinical review pending. How we prepare our guides

Common semaglutide side effects include nausea, vomiting, diarrhea, constipation and abdominal discomfort. Some improve as treatment continues, but severe or persistent symptoms need review. Do not assume that feeling unwell means the medicine is working better. MedlinePlus overview

Semaglutide is used in different products and formulations. The information here helps you prepare for follow-up; your own prescription and Medication Guide determine the instructions that apply to you.

How common are side effects?

The following figures come from the Wegovy label’s adult weight-reduction trials of the 2.4 mg once-weekly injection, not every semaglutide product or dose.

Reported event Wegovy 2.4 mg injection Placebo
Nausea 44% 16%
Diarrhea 30% 16%
Vomiting 24% 6%
Constipation 24% 11%

The groups included 2,116 participants receiving Wegovy and 1,261 receiving placebo. These are reports during trials, not a prediction of your experience or a comparison with another drug. Oral Wegovy and other injection doses have separate evidence. Wegovy prescribing information, section 6.1

Ozempic has its own studied populations, doses and adverse-event tables. Comparing percentages across separate trials can be misleading. For an actual treatment comparison, see semaglutide versus tirzepatide.

Which symptoms need urgent attention?

Seek emergency care for trouble breathing, swelling of the face or throat, collapse or other signs of a severe allergic reaction. Severe, persistent abdominal pain, especially if it spreads to the back, requires immediate medical assessment because it can signal pancreatitis. Stop the medicine and seek help if pancreatitis or a serious allergic reaction is suspected. Semaglutide patient information

Contact a clinician promptly about repeated vomiting, inability to keep fluids down, very little urine, significant dizziness, jaundice or new vision changes. Dehydration, gallbladder problems and eye complications are among the concerns described in prescribing information. Severe symptoms should not wait for a routine appointment. Ozempic safety information

This is not an exhaustive warning list. Keep the Medication Guide available and know who to call outside office hours.

Why do symptoms sometimes change with the dose?

GLP-1 medicines can cause more symptoms at higher doses, and some adverse effects improve as the body adjusts. Tell the prescriber about troublesome symptoms before the next planned increase. Do not speed up the schedule or change the dose yourself. MedlinePlus GLP-1 guide

Describe what you can eat and drink, whether symptoms interrupt sleep or work, and how long they last. Our food guide during GLP-1 treatment can help you organize that conversation. Persistent poor intake needs support, not praise for eating less.

Other precautions to raise before treatment

Semaglutide has a boxed warning about thyroid C-cell tumors observed in rodents; the relevance to humans is unknown. It is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. Wegovy boxed warning

Discuss insulin or sulfonylureas because combining them with semaglutide can increase the risk of low blood sugar. Also mention severe stomach-emptying problems, kidney issues, diabetic eye disease and planned anesthesia or deep sedation. Tell the procedural team about the medicine; do not invent your own pre-procedure stopping schedule. Ozempic precautions

Pregnancy plans require advance discussion. For weight management, semaglutide should be stopped when pregnancy is recognized, and the label specifies stopping at least two months before a planned pregnancy. Ask the prescriber to coordinate the plan. Wegovy pregnancy information

Can you avoid side effects by switching formulations?

A tablet, injection or compounded preparation is not automatically safer for you. Do not apply one product’s event rates to another. Our compounded semaglutide comparison explains why identity and approval matter.

For your review, bring the exact product, current dose, date of the last change, symptom timeline and complete medication list. Agree on what to do if symptoms recur and when to reassess. The aim is a tolerable, monitored treatment plan, not enduring symptoms without help.

More help with specific questions

Read the dedicated guides to constipation during GLP-1 treatment and hair loss on Wegovy and Ozempic. For everyday planning, use the meal guide and protein planner. Pephelp’s coaching supports agreed routines alongside your own prescriber or Pephelp care; it does not assess or treat side effects.

Sources and further reading

  1. Novo Nordisk: Wegovy US prescribing information (opens in a new tab)
  2. Novo Nordisk: Ozempic US prescribing information (opens in a new tab)
  3. MedlinePlus: semaglutide injection (opens in a new tab)
  4. MedlinePlus: GLP-1 agonists (opens in a new tab)

Source review October 17, 2026. Individual checks may be dated in the article. Prices, labels and policies can change. Linked studies being peer reviewed does not mean this article has been clinically reviewed.

GLP-1 coaching

A workable week. Someone in your corner.

Meals, movement and regular check-ins, whether your prescription comes from Pephelp or another provider. Coaching from $100/month, with an initial three-month commitment.

Explore GLP-1 coaching Use the free weekly support pack